167 related articles for article (PubMed ID: 18365023)
1. An integrative genomic and epigenomic approach for the study of transcriptional regulation.
Figueroa ME; Reimers M; Thompson RF; Ye K; Li Y; Selzer RR; Fridriksson J; Paietta E; Wiernik P; Green RD; Greally JM; Melnick A
PLoS One; 2008 Mar; 3(3):e1882. PubMed ID: 18365023
[TBL] [Abstract][Full Text] [Related]
2. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing.
Wu J; Wang SH; Potter D; Liu JC; Smith LT; Wu YZ; Huang TH; Plass C
BMC Genomics; 2007 May; 8():131. PubMed ID: 17524140
[TBL] [Abstract][Full Text] [Related]
3. PCDH17 functions as a common tumor suppressor gene in acute leukemia and its transcriptional downregulation is mediated primarily by aberrant histone acetylation, not DNA methylation.
Thanh Nha Uyen L; Amano Y; Al-Kzayer LFY; Kubota N; Kobayashi J; Nakazawa Y; Koike K; Sakashita K
Int J Hematol; 2020 Mar; 111(3):451-462. PubMed ID: 31865541
[TBL] [Abstract][Full Text] [Related]
4. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
5. H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA
Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
Nouzova M; Holtan N; Oshiro MM; Isett RB; Munoz-Rodriguez JL; List AF; Narro ML; Miller SJ; Merchant NC; Futscher BW
J Pharmacol Exp Ther; 2004 Dec; 311(3):968-81. PubMed ID: 15302897
[TBL] [Abstract][Full Text] [Related]
7. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia.
Wan L; Wen H; Li Y; Lyu J; Xi Y; Hoshii T; Joseph JK; Wang X; Loh YE; Erb MA; Souza AL; Bradner JE; Shen L; Li W; Li H; Allis CD; Armstrong SA; Shi X
Nature; 2017 Mar; 543(7644):265-269. PubMed ID: 28241141
[TBL] [Abstract][Full Text] [Related]
8. New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.
Kohlmann A; Schoch C; Dugas M; Schnittger S; Hiddemann W; Kern W; Haferlach T
Leukemia; 2005 Jun; 19(6):953-64. PubMed ID: 15815718
[TBL] [Abstract][Full Text] [Related]
9. Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
Zhou HR; Fu HY; Wu DS; Zhang YY; Huang SH; Chen CJ; Yan JG; Huang JL; Shen JZ
Oncol Rep; 2017 May; 37(5):2663-2671. PubMed ID: 28440495
[TBL] [Abstract][Full Text] [Related]
10. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
[TBL] [Abstract][Full Text] [Related]
11. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
Laskowska J; Lewandowska-Bieniek J; Szczepanek J; Styczyński J; Tretyn A
J Gene Med; 2016 Aug; 18(8):165-79. PubMed ID: 27280600
[TBL] [Abstract][Full Text] [Related]
12. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
13. Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL‑AF9 translocation.
Wang F; Li Z; Wang G; Tian X; Zhou J; Yu W; Fan Z; Dong L; Lu J; Xu J; Zhang W; Liang A
Mol Med Rep; 2020 Feb; 21(2):883-893. PubMed ID: 31789407
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells.
Sadikovic B; Andrews J; Carter D; Robinson J; Rodenhiser DI
J Biol Chem; 2008 Feb; 283(7):4051-60. PubMed ID: 18065415
[TBL] [Abstract][Full Text] [Related]
15. Identification of gene expression profiles that segregate patients with childhood leukemia.
Moos PJ; Raetz EA; Carlson MA; Szabo A; Smith FE; Willman C; Wei Q; Hunger SP; Carroll WL
Clin Cancer Res; 2002 Oct; 8(10):3118-30. PubMed ID: 12374679
[TBL] [Abstract][Full Text] [Related]
16. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
17. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing.
Cameron EE; Baylin SB; Herman JG
Blood; 1999 Oct; 94(7):2445-51. PubMed ID: 10498617
[TBL] [Abstract][Full Text] [Related]
18. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks.
Deneberg S; Guardiola P; Lennartsson A; Qu Y; Gaidzik V; Blanchet O; Karimi M; Bengtzén S; Nahi H; Uggla B; Tidefelt U; Höglund M; Paul C; Ekwall K; Döhner K; Lehmann S
Blood; 2011 Nov; 118(20):5573-82. PubMed ID: 21960591
[TBL] [Abstract][Full Text] [Related]
19. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
[TBL] [Abstract][Full Text] [Related]
20. Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles.
Yang XH; Wang B; Cunningham JM
BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S6. PubMed ID: 26043758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]